Common Contracts
2 similar Twelfth Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
TWELFTH SUPPLEMENTAL INDENTURETwelfth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
TWELFTH SUPPLEMENTAL INDENTURE, dated as of September 25, 2013 (the “Twelfth Supplemental Indenture”), by and among Labenne Participações Ltda. (“Labenne”), Probiótica Laboratórios Ltda. (“Probiótica”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
TWELFTH SUPPLEMENTAL INDENTURETwelfth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
TWELFTH SUPPLEMENTAL INDENTURE, dated as of September 25, 2013 (the “Twelfth Supplemental Indenture”), by and among Labenne Participações Ltda. (“Labenne”), Probiótica Laboratórios Ltda. (“Probiótica”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
